Laboratorios Grossman, S.A.
⚠️ High Risk
FEI: 3006330902 • Ciudad De Mexico, Ciudad de Mexico • MEXICO
FEI Number
3006330902
Location
Ciudad De Mexico, Ciudad de Mexico
Country
MEXICOAddress
Avenida Calzada De Tlalpan No. 2021, Col. Parque San Andres, Coyoacan, Ciudad De Mexico, Ciudad de Mexico, Mexico
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
NO ENGLISH
Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 10/27/2025 | 56JCL31CLINDAMYCIN PHOSPHATE (LINCOMYCINS) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/1/2025 | 60LCQ08BENZYDAMINE HCL (ANALGESIC) | Division of Southeast Imports (DSEI) | |
| 7/2/2025 | 66JAA02LIOTHYRONINE SODIUM (THYROID HORMONE) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 1/30/2023 | 62GDL95LOTEPREDNOL ETABONATE (ANTI-INFLAMMATORY) | Division of Southeast Imports (DSEI) | |
| 1/10/2023 | 65CDA99NUTRIENT/TONIC N.E.C. | Division of Southeast Imports (DSEI) | |
| 12/7/2022 | 65QCY60CYCLOBENZAPRINE HYDROCHLORIDE (RELAXANT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/17/2022 | 54YEY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/12/2022 | 66VCY99MISCELLANEOUS PATENT MEDICINES, ETC. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/6/2022 | 54YEY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/23/2022 | 64LCY67CLOBETASOL PROPIONATE (GLUCOCORTICOID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 7/1/2022 | 60BDA20METHIONINE (ACIDIFIER) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 11/30/2021 | 61CCK99ANTI-ANEMIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 9/30/2021 | 54ADB99VITAMIN, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/25/2021 | 54ADY05VITAMIN B12 (CYANOCOBALAMIN) | Division of Southeast Imports (DSEI) | |
| 4/20/2021 | 61VDB01SIMETHICONE (ANTI-FLATULENT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/1/2020 | 66PDY18ZINC OXIDE (ULTRAVIOLET SCREEN/SUNSCREEN) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 8/10/2020 | 66GCL25DIMETHICONE 350 (SURGICAL/PROSTHETIC AID) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/27/2020 | 61GCY81MUPIROCIN (ANTI-BACTERIAL, PART II) (NOT ANTIBIOTIC) | Division of Southeast Imports (DSEI) | |
| 1/24/2020 | 65CAK07LEVOCARNITINE (NUTRIENT/TONIC) | 3280FRNMFGREG | Division of Southeast Imports (DSEI) |
| 6/28/2019 | 61CCK99ANTI-ANEMIC, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/19/2019 | 61VAY01SIMETHICONE (ANTI-FLATULENT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/17/2019 | 54YBL99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C. | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/7/2019 | 63VCY02HYDROQUINONE (DEPIGMENTOR) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 10/18/2017 | 63VCY02HYDROQUINONE (DEPIGMENTOR) | Division of Southeast Imports (DSEI) | |
| 8/24/2016 | 56YCB99ANTIBIOTIC N.E.C. | 75UNAPPROVED | New Orleans District Office (NOL-DO) |
| 4/1/2016 | 65NCY16CYANOCOBALAMIN CO 57 (RADIOACTIVE AGENT) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 2/24/2010 | 54CCR02L-ARGININE (PROTEIN) | Cincinnati District Office (CIN-DO) | |
| 5/23/2007 | 54AGK05VITAMIN B12 (CYANOCOBALAMIN) | Cincinnati District Office (CIN-DO) | |
| 5/22/2007 | 65CNK07LEVOCARNITINE (NUTRIENT/TONIC) | 27DRUG GMPS | Cincinnati District Office (CIN-DO) |
| 5/28/2003 | 65CCP07LEVOCARNITINE (NUTRIENT/TONIC) | Cincinnati District Office (CIN-DO) | |
| 3/26/2003 | 54AFK02VITAMIN B1 (THIAMINE) | 324NO ENGLISH | Chicago District Office (CHI-DO) |
Frequently Asked Questions
What is Laboratorios Grossman, S.A.'s FDA import refusal history?
Laboratorios Grossman, S.A. (FEI: 3006330902) has 31 FDA import refusal record(s) in our database, spanning from 3/26/2003 to 10/27/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios Grossman, S.A.'s FEI number is 3006330902.
What types of violations has Laboratorios Grossman, S.A. received?
Laboratorios Grossman, S.A. has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Laboratorios Grossman, S.A. come from?
All FDA import refusal data for Laboratorios Grossman, S.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.